about
Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomographyIn vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.Nitrogen-13: historical review and future perspectives.Efficacy assessment of self-assembled PLGA-PEG-PLGA nanoparticles: Correlation of nano-bio interface interactions, biodistribution, internalization and gene expression studies.PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats.Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer.An iron oxide nanocarrier for dsRNA to target lymph nodes and strongly activate cells of the immune system.COSAN as a molecular imaging platform: synthesis and "in vivo" imaging.Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels.Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.Novel 18F labeling strategy for polyester-based NPs for in vivo PET-CT imaging.In vivo imaging of dopaminergic neurotransmission after transient focal ischemia in ratsSynthesis and in vivo evaluation of (11) C-labeled (1,7-dicarba-closo-dodecaboran-1-yl)-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}amide.68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation.Synthesis of S-[13N]nitrosoglutathione (13N-GSNO) as a new potential PET imaging agent.P2X4 receptors control the fate and survival of activated microglia.Straightforward synthesis of radioiodinated Cc-substituted o-carboranes: towards a versatile platform to enable the in vivo assessment of BNCT drug candidates.Biocatalysis in Radiochemistry; Enzymatic Incorporation of PET radionuclides into molecules of biomedical interest.Evaluation of the novel TSPO radiotracer [18F] VUIIS1008 in a preclinical model of cerebral ischemia in rats.Medical Imaging for the Tracking of Micromotors.In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.Synthesis and evaluation of (13)N-labelled azo compounds for β-amyloid imaging in mice.Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo.In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia.Assessing lung inflammation after nanoparticle inhalation using 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging.Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles.Efficient Enzymatic Preparation of (13) N-Labelled Amino Acids: Towards Multipurpose Synthetic Systems.Synthesis and 11C-Radiolabelling of 2-Carboranyl Benzothiazoles.Radiolabeled Nanoparticles for Cancer Diagnosis and Therapy.A convenient synthesis of 13N-labelled azo compounds: a new route for the preparation of amyloid imaging PET probes.Specific activity of [11C]CH3I synthesized by the "wet" method: main sources of non-radioactive carbon.Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2h-transient focal ischemiaEfficient system for the preparation of [13N]labeled nitrosaminesSynthesis of 11C-labeled Kendine 91, a histone deacetylase inhibitorBiodistribution and metabolism of 11C-labeled Kendine 91 in mice and ratsFully automated and reproducible radiosynthesis of high specific activity [¹¹C]raclopride and [¹¹C]Pittsburgh compound-B using the combination of two commercial synthesizersTracing nanoparticles in vivo: a new general synthesis of positron emitting metal oxide nanoparticles by proton beam activation[18F]fluorination of o-carborane via nucleophilic substitution: towards a versatile platform for the preparation of 18F-labelled BNCT drug candidates
P50
Q36765878-079E7C90-A683-4207-8633-08E61EE8220AQ36893415-14CE0428-A51E-4AB8-B5D0-ADBE3CF74044Q37202278-20F28A41-8CD8-47EA-A223-EA302D44A0D6Q38178579-AADC5886-5FDE-4C4D-9F52-51A128417E8EQ38759211-C67DBCA4-7494-4C61-8936-DA0D96CC7FD0Q38771463-39B8E1DF-9B37-42F4-8C17-03AE9B9D1205Q38851181-194BE3EB-A899-4069-ACCE-EFD779D677AEQ38966014-6F1DEA63-F36A-4320-A820-E40BCACE5961Q39144008-28030BF4-B893-404C-B3E5-343EE5738EA6Q40238471-7C898257-0877-4B95-8228-16183E14B819Q40867375-0EF29D4F-960A-4A51-9ED7-A8C93F0537BCQ41358843-16EAF128-4A9F-4AA5-9B4C-31405135A58FQ41834438-3FEBFF18-0948-49BF-BDE3-5BC6F1961D31Q43503111-3DD3B65A-5B23-4418-9B3D-D905AC214B7CQ46083926-76B577A1-4B98-4205-B144-EFA8292C0229Q46237825-F4B9A7C8-E200-4B95-BA47-E1D937C03A87Q46356718-7ADF8147-1073-4EE3-8375-8188BE6B8EFBQ46733902-727402B4-7711-4E8F-ACFD-FB6899D35DEEQ47258876-3AAC997D-8720-412A-A5AC-457A0EA5B484Q47361841-1CFFA66E-5F8C-4243-B539-8A828D66A4BBQ48183973-D3697A70-006C-4542-8C90-B19C9E038743Q48200554-E22A50F6-FA67-45DC-A718-18F2416D0308Q48823625-07802F96-21B6-4739-9556-535999FA6DEAQ50062968-44E3A2E8-51A1-4011-BC7B-AF3EA44DBE34Q51527750-CC037109-13A5-454B-944A-83F63FC262EAQ51741400-0AD96E9F-3B0D-4A44-9C31-B536E06080E4Q51787158-9ADB0E54-31FC-4D08-872F-6144B11B5009Q51826368-684B46BE-060F-497D-AF59-F2912F658E4DQ52977417-8981D7B7-ED85-455F-81E0-B2A49FD4E7C0Q53012810-E62000DE-9822-4353-88E8-0A5502A5654AQ53205991-43ED4BF5-CEDC-4296-A978-A8927AD82740Q53272973-67F2D8B0-60B5-4FF9-BDF6-D5F3E2751115Q53386523-A060E517-8837-4892-87E8-7BE16147D37FQ60620006-97E249B1-6AB3-47A0-900C-B2E179A66D0AQ83445277-0AA6D4E2-73C3-4607-B7EC-8E643113EA81Q84747769-D1BE2ACC-8D52-479B-B8FB-474891AF74A1Q84747772-228392D7-92E5-49AD-9697-28834EA3E2FBQ84902290-2AB5DE9B-837F-457D-AE93-241951D1E5A2Q84945341-1A38E621-E788-494D-8533-12A98BAD7412Q86618549-6A493780-59DA-4DBD-8C74-4DEB25189AE6
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Vanessa Gomez Vallejo
@ast
Vanessa Gomez Vallejo
@en
Vanessa Gomez Vallejo
@es
Vanessa Gomez Vallejo
@nl
type
label
Vanessa Gomez Vallejo
@ast
Vanessa Gomez Vallejo
@en
Vanessa Gomez Vallejo
@es
Vanessa Gomez Vallejo
@nl
prefLabel
Vanessa Gomez Vallejo
@ast
Vanessa Gomez Vallejo
@en
Vanessa Gomez Vallejo
@es
Vanessa Gomez Vallejo
@nl
P31
P496
0000-0003-3995-9596